Cardiorenal differences among NSAIDs and coxibs: real-world experience.
作者信息
Sonnenblick Edmund H
机构信息
Division of Cardiology, Weiller Hospital of the Albert Einstein College of Medicine, Bronx, New York, USA.
出版信息
Am J Manag Care. 2002 Oct;8(15 Suppl):S369-70.
PMID:12416786
Abstract
摘要
相似文献
1
Cardiorenal differences among NSAIDs and coxibs: real-world experience.
Am J Manag Care. 2002 Oct;8(15 Suppl):S369-70.
2
3
4
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.骨关节炎和类风湿关节炎患者症状性治疗的新方向。
Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):4-14. doi: 10.1053/sarh.2002.37215.
5
[Is there a future for COX-2 inhibitors?].[环氧化酶-2抑制剂还有未来吗？]
Harefuah. 2004 Nov;143(11):820-4, 837.
6
Gastrointestinal outcomes: evidence for risk reduction in patients using coxibs.
Am J Manag Care. 2002 Nov;8(17 Suppl):S518-28.
7
Increased risk of cardiovascular events with coxibs and NSAIDs.昔布类药物和非甾体抗炎药会增加心血管事件风险。
Lancet. 2005;365(9470):1537. doi: 10.1016/S0140-6736(05)66445-8.
8
[Migraine, juvenile rheumatoid arthritis, prevention of cancer. Potential of coxibs has not been exhausted].
MMW Fortschr Med. 2004 Apr 22;146(17):57.
9
Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.对尤尼·P、迪耶普·P的评论：不应给老年人开“昔布类药物”来替代传统的非甾体抗炎药。
Age Ageing. 2004 Sep;33(5):521. doi: 10.1093/ageing/afh207.
Zotero 插件